European Survey of Prescriber Understanding of Risks Associated with Retigabine.

ABSTRACT:

Background

We conducted a survey to assess physicians' knowledge and understanding of key risks associated with retigabine.

Objective

The survey evaluated the effectiveness of the educational plan for retigabine, as specified in the GlaxoSmithKline (GSK) European Risk Management Plan.

Methods

This was a cross-sectional survey of physicians across seven European countries (Denmark, Germany, Norway, Slovakia, Spain, Switzerland, and the UK) who had prescribed an antiepileptic drug at least once within the past 3 months, and to whom a letter containing the retigabine Physician's Guide was sent. The survey included multiple-choice and closed-ended questions. Primary outcome was the proportion of physicians correctly answering questions related to retigabine-associated ris

SUBMITTER: Ishihara L 

PROVIDER: S-EPMC4674521 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature